FDA Investigator Anna Lazar
Anna Lazar has inspections in 12 countries as of 15 Sep 2023. Anna Lazar has collaborated with a combinined 3363 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
46
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Sweden,
Italy,
Hungary,
Germany,
Canada,
Japan,
United Kingdom of Great Britain and Northern Ireland,
France,
Finland,
United States of America,
Czechia,
Switzerland
Co-Investigator(s):
Alan P Kurtzberg,
Alberto A Viciedo,
Alicia M Mozzachio,
Allen F Hall,
Anastasia M Shields,
Angela E Glenn,
Anissa M Vargas,
Anita R Michael,
Anthony C Warchut,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Audrey Thereset Uy,
Azza Talaat,
Barbara J Rincon,
Barbara Janine Breithaupt,
Barbara M Frazier,
Bogdan Kurtyka,
Bonita S Chester,
Brian D Young,
Brooke K Higgins,
Carl Lee,
Carla A Norris,
Carla J Lundi,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charisse K Green,
Charles I Ann,
Charles M Edwards,
Charles R Cote, RIC,
Cheryl Llove Harris,
Christine W Twohy,
Cody D Rickman,
Crayton Lee,
Cynthia A Palmer,
Dale A Nyberg,
Daniel W Johnson,
David A Oluwo,
David M Beltran,
Dennis Cantellops Paite,
Dennis R Downer,
Derek S Dealy,
Doan T Nguyen, PharmD,
Douglas C Kovacs,
Edmund F Mrak, Jr,
Edwin L Hobbs,
Ellen P Madigan,
Felix Maldonado,
Francis A Guidry,
Freddy Ortiz Colon,
Frederick Razzaghi,
Gam S Zamil,
Gerardo Z Vazquez,
Ginger M Sykes,
Gwyn G Dickinson,
Ivis Lnegron Torres,
James A Lane,
James A Liubicich,
James P Mcreavey,
James P Stumpff,
Jay T Wong,
Jeffrey A Sommers,
Joan T Briones,
Jogy George,
John P Mistler,
Jorge L Guadalupe,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose R Hernandez,
Joseph J Vannelli,
Joseph T Dougherty,
Joshua P Wireman,
Judith A Paterson,
Junho Pak,
Justine Tomasso,
Karen L Kosar,
Karlton T Watson,
Karyn M Campbell,
Kellia N Hicks,
Kelvin Cheung,
Kenneth H Williams,
Kevin A Gonzalez,
Kevin P Foley,
Khoa Nathanv Tran,
Kim Lthomas Cruse,
Kristen D Evans,
Kristy A Zielny,
Lance M De Souza, MBA,
Larry K Austin,
Laurie B Frazier,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
LCDR Michael H Tollon,
Lequita M Mayhew,
Liatte Kreuger, PharmD,
Lillie D Witcher,
Lisa Shin,
Luella J Rossi,
Luis A Dasta,
Lynnette I Riggio,
Marcus F Yambot,
Margaret M Annes,
Maria A Ruttell,
Maribeth G Niesen,
Marie A Fadden,
Mark R Mcclain,
Matthew B Casale,
Matthew J Sienko,
Matthew R Noonan,
Maureen A Wentzel,
Melissa J Garcia,
Meredith L Sheridan,
Michael A Charles,
Michael L Chasey,
Michael R Goga,
Michael W Burd,
Michele L Forster, PhD,
Michele L Obert,
Michele Perry Williams,
Monica M Mcclure,
Mra Davism,
Mra M Barbosar,
Mra Mcculloughj,
Nancy M Lazzari,
Nicholas A Violand,
Nicholas L Paulin,
Pal S Mayasandra,
Parul M Patel,
Patrick C Klotzbuecher,
Paula A Trost,
Raquel Gonzalez Rivera,
Raymond T Oji,
Reba A Gates,
Rebecca E Dombrowski,
Robert D Tollefsen,
Robert J Martin,
Rochelle L Cross,
Rodney G Raiford,
Rory K Geyer,
Russell J Glapion,
Russell K Riley,
Saied A Asbagh,
Santos E Camara,
Sarah E Mcmullen,
Sarah M Meng,
Sarah M Napier,
Scott T Ballard,
Sharon Mills,
Shirley J Berryman,
Simone E Pitts,
Sixto M Mercado Rios,
Sneha S Patel,
Sonia R Peterson,
Stephanie A Slater, MS,
Stephen J Mottola,
Steven A Gonzales,
Steven C Madzo,
Steven M Weinman,
Steven P Donald,
Sullivanm,
Susan F Laska, MS,
Tamil Arasu, PhD,
Terri L Dodds,
Thomas J Arista,
Thomas W Nojek,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Tiffani D Wilson,
Timothy T Kapsala,
Tina M Pawlowski,
Tonya O Corbin,
Torrance J Slayton,
Travers,
Truong Xuan Nguyen (Andy),
Uduak M Inokon,
Unnee Ranjan,
Veronica Fuentes, MS,
Victoria A Wagoner,
Vilmary Negron Rodriguez,
Vlada Matusovsky,
Walden H Lee,
Wendy G Tan, PhD,
William J Leonard,
Yong Hu,
Yumi J Hiramine,
Zhihao Qiu (Peter), PhD,
Zhong Li, PhD
Anna Lazar's Documents
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more